This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 High-Potential Small-Caps With Market Cap Under $1B.
We came across a bullish thesis on Prothena Corporation plc on BiotechBonanza’s Substack by AnotherBio. In this article, we will summarize the bulls’ thesis on PRTA. Prothena Corporation plc's share was trading at $9.92 as of October 3rd. PRTA’s forward P/E was 33.90 according to Yahoo Finance.
[caption id="attachment_942841" align="aligncenter" width="750"]Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.